Navigate Up

UPMC/University of Pittsburgh Schools of the Health Sciences

Our Experts

Evelyn Talbott, Dr.P.H.

Polycystic Ovary Syndrome May Lead to Early Onset of Atherosclerosis, Even Among Thin Women, According to University of Pittsburgh Study

PITTSBURGH, November 9, 2000 — Young women with polycystic ovary syndrome (PCOS) have metabolic abnormalities, including higher levels of lipids and insulin, that may result in premature atherosclerosis by middle age, according to a University of Pittsburgh study published in the November issue of Arteriosclerosis, Thrombosis and Vascular Biology.

PCOS is one of the most common reproductive disorders, affecting approximately five percent of women in the United States. It is characterized by menstrual irregularities, excessive body hair, infertility, high insulin levels and, often, obesity.

University of Pittsburgh researchers have found that women with PCOS are also at high risk of developing early-onset atherosclerosis, even if they are thin. This connection is due to their lifetime of exposure to higher levels of cardiovascular disease risk factors, such as insulin and LDL, or "bad," cholesterol.

Despite these dangers, PCOS often goes undiagnosed.

"Women with PCOS are usually seen by their doctors for symptoms such as menstrual irregularities or infertility," said Evelyn Talbott, Dr.P.H., associate professor of epidemiology at the University of Pittsburgh Graduate School of Public Health (GSPH) and principal investigator on the study. "Because it appears that PCOS may cause early onset of atherosclerosis, these women may represent the largest female group at high risk for the development of early onset coronary heart disease. Therefore it is important that physicians recognize these reproductive symptoms as signs of a broader, chronic disorder and treat it accordingly with early lifestyle interventions and/or medications that will reduce cardiovascular disease risks."

In this cross-sectional study, researchers looked for evidence of premature carotid atherosclerosis among women with PCOS who were at least 30 years of age. Participants included 125 PCOS patients and 142 control women. Cases and controls had similar general characteristics such as age and general health. However, women with PCOS had notably higher cardiovascular risk factors.

All study participants underwent ultrasonography of the carotid arteries in the neck to evaluate the presence of carotid plaque and carotid intima-media wall thickness (IMT), two signs of atherosclerosis that predict cardiovascular disease.

Researchers found that 21.6 percent of women with PCOS had plaque in their carotid arteries, compared with only 15.5 percent of women in the control group. Also, PCOS patients age 45 and over had more significant plaque than did the controls. Likewise, IMT was significantly higher among PCOS cases after the age of 45, compared with slight elevations among control women.

Among all participants under the age of 45, IMT was associated with cardiovascular disease risk factors including age, body-mass index, blood pressure, waist-to-hip ratio and triglycerides. In women over 45, however, PCOS was a greater predictor of IMT.

"These findings show that, with lifelong exposure to high levels of cardiovascular disease risk factors, women with PCOS may begin to develop atherosclerosis by the age of 45, which is younger than is seen in the normal population," explained Dr. Talbott. "These results are consistent among the PCOS women studied, regardless of their weight."

In 1992, Dr. Talbott led a study showing that women ages 20-49 with PCOS had elevations in other cardiovascular disease risk factors compared with controls of similar age. These risk factors included a higher body mass index and waist-to-hip ratio, increased LDL cholesterol, insulin and systolic blood pressure, and lower HDL ("good") cholesterol. LDL cholesterol levels were higher for PCOS women under the age of 40, even among those who were relatively slender. Normally, risk factors such as high LDL levels are more common in overweight individuals. Among participants age 40 and older, the difference in LDL levels between cases and controls was less evident. This is due to women in that age group reaching perimenopause, when control women are likely to experience increases in LDL levels and "catch up" to PCOS women.

Both studies were supported by the National Institutes of Health (NIH). Dr. Talbott recently received an additional NIH research grant of $1.7 million to evaluate factors affecting the progression of carotid atherosclerosis in PCOS women over a five-year period. The study, slated to begin in March 2001, will use electron beam computed tomography to evaluate coronary artery calcification, a potential predictor of cardiovascular events.

Established in 1948, the GSPH at the University of Pittsburgh is world-renowned for contributions that have influenced public health practices and medical care for millions of people. It is the only fully accredited school of public health in the Commonwealth of Pennsylvania and is one of the top-ranked schools of public health in the United States. It is one of eight schools across the nation to be designated a Public Health Training Center by the U.S. Department of Health and Human Services. For more information about the GSPH, access the school’s website at http://www.publichealth.pitt.edu/.

©  UPMC | Affiliated with the University of Pittsburgh Schools of the Health Sciences
Supplemental content provided by A.D.A.M. Health Solutions. All rights reserved.

For help in finding a doctor or health service that suits your needs, call the UPMC Referral Service at 412-647-UPMC (8762) or 1-800-533-UPMC (8762). Select option 1.

UPMC is an equal opportunity employer. UPMC policy prohibits discrimination or harassment on the basis of race, color, religion, ancestry, national origin, age, sex, genetics, sexual orientation, marital status, familial status, disability, veteran status, or any other legally protected group status. Further, UPMC will continue to support and promote equal employment opportunity, human dignity, and racial, ethnic, and cultural diversity. This policy applies to admissions, employment, and access to and treatment in UPMC programs and activities. This commitment is made by UPMC in accordance with federal, state, and/or local laws and regulations.

Medical information made available on UPMC.com is not intended to be used as a substitute for professional medical advice, diagnosis, or treatment. You should not rely entirely on this information for your health care needs. Ask your own doctor or health care provider any specific medical questions that you have. Further, UPMC.com is not a tool to be used in the case of an emergency. If an emergency arises, you should seek appropriate emergency medical services.

For UPMC Mercy Patients: As a Catholic hospital, UPMC Mercy abides by the Ethical and Religious Directives for Catholic Health Care Services, as determined by the United States Conference of Catholic Bishops. As such, UPMC Mercy neither endorses nor provides medical practices and/or procedures that contradict the moral teachings of the Roman Catholic Church.

© UPMC
Pittsburgh, PA, USA UPMC.com